These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 34303620)

  • 1. First Case Report of Euglycemic Diabetic Ketoacidosis With an Automated Insulin Pump in a 12-Year-Old Patient With Type 1 Diabetes Mellitus.
    Phung K; Henderson M; Geoffroy L
    Can J Diabetes; 2022 Feb; 46(1):81-83. PubMed ID: 34303620
    [No Abstract]   [Full Text] [Related]  

  • 2. A Case Report of Diabetic Ketoacidosis With Combined Use of a Sodium Glucose Transporter 2 Inhibitor and Hybrid Closed-Loop Insulin Delivery.
    Singh S; Rushakoff RJ; Neinstein AB
    J Diabetes Sci Technol; 2019 May; 13(3):605-606. PubMed ID: 30931610
    [No Abstract]   [Full Text] [Related]  

  • 3. Sodium-glucose cotransporter 2 inhibitor-induced euglycemic diabetic ketoacidosis in a patient with coronavirus disease 2019: a case report.
    Yii ESS; Azli AW; Sitaram PN
    J Med Case Rep; 2022 Jan; 16(1):17. PubMed ID: 34983625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence of Euglycemic Diabetic Ketoacidosis in Adults With Type 1 Diabetes in the United Kingdom Before the Widespread Use of Sodium Glucose Cotransporter 2 Inhibitors.
    Macfarlane J; Dhatariya K
    Mayo Clin Proc; 2019 Sep; 94(9):1909-1910. PubMed ID: 31486388
    [No Abstract]   [Full Text] [Related]  

  • 5. Euglycemic diabetic ketoacidosis.
    González-Castro A; Ortiz Lasa M; Jiménez Alfonso A
    Med Clin (Barc); 2019 May; 152(10):416-417. PubMed ID: 30017208
    [No Abstract]   [Full Text] [Related]  

  • 6. A Case of Euglycemic Diabetic Ketoacidosis due to Empagliflozin Use in a Patient with Type 1 Diabetes Mellitus.
    Bilgin S; Duman TT; Kurtkulagi O; Yilmaz F; Aktas G
    J Coll Physicians Surg Pak; 2022 Jul; 32(7):928-930. PubMed ID: 35795946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SGLT2 Inhibitors and Euglycemic Ketoacidosis.
    Masuta P; Johri G; Paul M
    Am J Ther; 2018; 25(4):e498-e500. PubMed ID: 28537992
    [No Abstract]   [Full Text] [Related]  

  • 8. Sodium–glucose co-transporter 2 inhibitors: Think twice about diabetic ketoacidosis.
    Markey AG; Scott TA; Killen JC; Venter JA
    Aust J Gen Pract; 2018 Apr; 47(4):223-225. PubMed ID: 29621864
    [No Abstract]   [Full Text] [Related]  

  • 9. [Diabetic euglycemic ketosis or ketoacidosis in individuals with type 2 diabetes treated by SGLT2 inhibitors: A series of Belgian clinical cases].
    Menghoum N; Oriot P; Hermans MP; Mariage JL
    Rev Med Interne; 2020 Apr; 41(4):226-231. PubMed ID: 31866073
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A project identifying potential risk factors leading to diabetic ketoacidosis in patients with type 1 diabetes treated with an insulin pump.
    Caines CM; Shaw A; Solomon AM
    Clin Med (Lond); 2020 Mar; 20(2):233-234. PubMed ID: 32188670
    [No Abstract]   [Full Text] [Related]  

  • 11. [Diabetic ketoacidosis by exposure of insulin pump to heat and sunlight].
    Pryce R
    Praxis (Bern 1994); 2009 May; 98(10):543-5. PubMed ID: 19424950
    [No Abstract]   [Full Text] [Related]  

  • 12. Euglycemic Ketoacidosis With Sodium-Glucose Cotransporter-2 Inhibitor.
    Koch RA; Clark RF
    Am J Ther; 2018; 25(5):e590-e591. PubMed ID: 28452848
    [No Abstract]   [Full Text] [Related]  

  • 13. Diabetic Ketoacidosis With Canagliflozin, a Sodium-Glucose Cotransporter 2 Inhibitor, in Patients With Type 1 Diabetes.
    Peters AL; Henry RR; Thakkar P; Tong C; Alba M
    Diabetes Care; 2016 Apr; 39(4):532-8. PubMed ID: 26989182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intraoperative Diagnosis of Sodium-Glucose Cotransporter 2 Inhibitor-Associated Euglycemic Diabetic Ketoacidosis: A Case Report.
    Seger CD; Xing H; Wang L; Shin JS
    A A Pract; 2021 Jan; 15(1):e01380. PubMed ID: 33512907
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Euglycemic diabetic ketoacidosis associated with the use of a sodium-glucose cotransporter-2 inhibitor.
    Zhang L; Tamilia M
    CMAJ; 2018 Jun; 190(25):E766-E768. PubMed ID: 29941433
    [No Abstract]   [Full Text] [Related]  

  • 16. Successful treatment of nivolumab and ipilimumab triggered type 1 diabetes by using sodium-glucose transporter 2 inhibitor: a case report and systematic review.
    Fujiwara M; Shimizu M; Okano T; Maejima Y; Shimomura K
    Front Public Health; 2023; 11():1264056. PubMed ID: 38106883
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early detection of euglycemic ketoacidosis during thoracic surgery associated with empagliflozin in a patient with type 2 diabetes: A case report.
    Kitahara C; Morita S; Kishimoto S; Matsuno S; Uraki S; Takeshima K; Furukawa Y; Inaba H; Iwakura H; Ariyasu H; Furuta H; Nishi M; Akamizu T
    J Diabetes Investig; 2021 Apr; 12(4):664-667. PubMed ID: 32686282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sodium-glucose co-transporter inhibitors, their role in type 1 diabetes treatment and a risk mitigation strategy for preventing diabetic ketoacidosis: The STOP DKA Protocol.
    Goldenberg RM; Gilbert JD; Hramiak IM; Woo VC; Zinman B
    Diabetes Obes Metab; 2019 Oct; 21(10):2192-2202. PubMed ID: 31183975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diabetic ketoacidosis in patients under treatment with sodium-glucose cotransporter type 2 inhibitors.
    López Medina JA; Hernández García C; Espíldora Hernández J
    Med Clin (Barc); 2017 Oct; 149(7):311-312. PubMed ID: 28662890
    [No Abstract]   [Full Text] [Related]  

  • 20. Assessing the risk of ketoacidosis due to sodium-glucose cotransporter (SGLT)-2 inhibitors in patients with type 1 diabetes: A meta-analysis and meta-regression.
    Musso G; Sircana A; Saba F; Cassader M; Gambino R
    PLoS Med; 2020 Dec; 17(12):e1003461. PubMed ID: 33373368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.